NICOLE ORIZONDO: Open Payments
NPI 1750795415 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,629 in 50 payments from 13 companies in 2025. Trend: 2023 $2,013 · 2024 $1,114 · 2025 $1,629
Food & beverage: $1,629
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 22 | $666 |
| Cleerly, Inc. | 8 | $385 |
| Medtronic, Inc. | 6 | $156 |
| Kestra Medical Technology Services, Inc. | 2 | $85 |
| Boston Scientific Corporation | 3 | $68 |
| Edwards Lifesciences Corporation | 1 | $61 |
| Inspire Medical Systems, Inc. | 1 | $53 |
| Biosense Webster, Inc. | 2 | $41 |
| BridgeBio Pharma, Inc. | 1 | $33 |
| Baxter Healthcare | 1 | $21 |
Products named: AVEIR, Cleerly Ischemia, LINQ II, Assure WCD, EVOQUE, WATCHMAN FLX, INSPIRE, CARTO 3.
Industry payments across FL — which companies pay providers there.
